PJSC Farmak pharmaceutical company (Kyiv) has presented a new laboratory and technological complex, with investment in the facility totaling UAH 100 million since 2012.
The company told Interfax-Ukraine that investment in the laboratory and processing facility will be repaid within two or three years.
The facility has received a certificate of compliance with GMP. Its production lines will manufacture laboratory, pilot and clinical series of drugs allowing it to produce the latest high tech medicine and generic drugs.
Using the new laboratory and processing facility will enable, in particular, optimizing the transfer of technologies for the production of new drugs and will speed up the development of solid, liquid, soft dosage forms and soft gelatin capsules, sterile and aseptic preparations and so forth.
The complex laboratories are equipped with high tech equipment of the leading brands including Glatt, SBM, Urlinski, Belimed, De Ditrich, Gea, Sartorius, Malvern Instruments and others.
Advertising
Advertising
MORE ABOUT
Farmak buys marketing pharmaceutical companies in the Czech Republic, Slovakia, Ukraine
10:46, 05.06.2023
Less than 5% of Farmak employees who left Ukraine because of war remain abroad
20:20, 28.04.2023
Shareholders of Farmak pharmaceutical company re-elect supervisory board, its head
10:23, 15.06.2022
EBRD provides EUR 20 mln loan to Farmak
18:14, 26.05.2022
Farmak invests over $1.2 mln in MedTech, HealthCare projects and startups
14:13, 05.01.2022
LATEST
USA to allocate over $190 mln to support Ukraine's energy sector over five years
20:22, 08.05.2024
Shmyhal orders to approve restoration schedules for energy facilities, reinforce their defense before next heating season
18:56, 08.05.2024
Ukrenergo will limit industrial consumers, businesses from 18:00 to 23:00, emergency shutdowns for public possible
17:42, 08.05.2024
Naftogaz Group receives UAH 23.1 bln net profit in 2023 against UAH 79.1 bln loss in 2022
12:52, 07.05.2024
After opening of sea exports, Metinvest increases workload of factories, directs efforts to retain teams – HR Director